Aspirin-triggered lipid mediators

Details Aspirin-triggered lipid mediators Aspirin-triggered lipid mediators

2006-05-30

2006-05-30

Kumar, Shailendra (Department: 1621)

Organic compounds -- part of the class 532-570 series

Organic compounds

Fatty compounds having an acid moiety which contains the...

C554S115000, C554S219000, C562S579000, C514S560000

Reexamination Certificate

active

07053230

ABSTRACT:
Aspirin triggered lipid mediators (ATLMs) are disclosed which are useful for the treatment of prevention of inflammation associated with various diseases, including ischemia.

REFERENCES:
patent: 4201211 (1980-05-01), Chandrasekaran et al.
patent: 4666701 (1987-05-01), Horrobin et al.
patent: 4810424 (1989-03-01), Gerwick et al.
patent: 5409955 (1995-04-01), Bockow et al.
patent: 5411988 (1995-05-01), Bockow et al.
patent: 5709855 (1998-01-01), Bockow
patent: 5814599 (1998-09-01), Mitragotri et al.
patent: 5846974 (1998-12-01), Kallman et al.
patent: 6201022 (2001-03-01), Mease et al.
patent: 5186342 (1993-07-01), None
patent: WO 91/16914 (1991-11-01), None
patent: WO 98/46588 (1998-10-01), None
CA 101:19194 for VanRollins et al, Journal of Biological Chemistry, (1984) 259(9), pp. 5776-83.
CA 119:265901 for Reynaud et al, Analytical Biochemistry (1993), 214(1), pp. 165-170.
Miller et al, Lipids, 24(12), pp. 998-1003 (1989).
PCT/US01/05196 International Search Report.
J.W. Karanian et al., “Physiological functions of hydroxy—docosahexaenoic acid”, Abstract, XP-002200246, 1993.
E.M. Hill, et al. “Identification and egg hatching activity of monohydroxy fatty acid eicosanoids in the barnacle Balanus balanoides”, Abstract, XP-002200247, 1992.
L. De Montarby, et al. “Synthesis stereoselectives de metabolites hydroxyles d'acides gras polinsatures”, Bulletin De La Societe Chimique de France, No. 3, pp. 419-432, 1989.
M. Yamane, et al., “Docosahexaenoic/arachidonic acid ω-hydroxylation system and differentiation in the human clonic adenocarcinoma cell line, Caco-2”, Cancer Letters, vol. 122, pp. 51-59, 1998.
T. Kato, et al., “Production of Hydroxy Unsaturated Fatty Acids Using Crude Lipoxygenase Obtained from Infected Rice Plants”, Bull. Chem. Soc. Jpn. vol. 69, pp. 1663-1666, 1996.
W.E.M. Lands, “Proceedings of the AOCS Short Course on Polyunsaturated Fatty Acids and Elcosanoids”,American Oil Chemists' Society1987.
M. Ligo et al., “Inhibitory effects of docosahexaenoic acid on colon carcinoma 26 metastasis to the lung”,Br. J. Cancer, 1997, pp. 650-655.
G.E. Billman et al., “Prevention of sudden cardiac death by dietary pure ω-3 polyunsaturated fatty acids in dogs”,Circulation99 1999, pp. 2452-2457.
A.P. Simopoulos, “Workshop on the essentiality of an recommended dietary intakes for omega-6 and omega-3 fatty acids”,J. Am. Coll. Nutr. 1999, pp. 487-489.
R. Marchioloi, “Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial Infarction: results of the GISSI-Prevenzione trial”,Lancet1999, pp. 447-455.
G. Weissmann, “Aspirin”,Sci. Am. 1991, pp. 84-90.
A.J. Marcus, “Platelets: their role in hemostasis, thrombosis, and inflammation”,Inflammation: Basic Principles and Clinical Correlates1999, pp. 77-95.
J. Claria et al., “Aspirin triggers previously undescribed bioactive eicosanoids by human endothelial cell-leukocyte interactions”,Proc. Natl. Acad. Sci. USA1995, pp. 9475-9479.
C.N. Serhan et al, “Design of lipoxin A4 stable analogs that block transmigration and adhesion of human neutorphils”,Biochemistry1995, pp. 14609-14615.
N. Chiang et al., “Leukotriene B4 receptor transgenic mice reveal novel protective roles for lipoxins and aspirin-triggered lipoxins in reperfusion”,J. Clin. Invest. 1999, pp. 309-316.
H.R. Herschman, “Recent progress in the cellular and molecular biology of prostaglandin synthesis”,Trends Cardiovasc. Med. 1998, pp. 145-150.
P. Needleman et al., “The discovery and function of COX-2”,J. Rheumatol1997, pp. 6-8.
N. Chiang et al., “Aspirin-triggered 15-epi-lipoxin A4 (ATL) generation by human leukocytes and murine peritonitis exudates: Development of a specific 15-epi-LXA4 ELISA”,J. Pharmacol. Exp. Ther. 1998, pp. 779-790.
G. Xiao et al., “Analysis of hydroperoxide-induced tyrosyl radicals and lipoxygenase activity in aspirin-treated human prostaglandin H synthase-2”,Biochemistry1997, pp. 1836-1845.
K. Node et al., “Anti-inflammatory properties of cytochrome P450 epoxygenase-derived eicosanoids”,Science1999, pp. 1276-1279.
S. Sethi et al., “Inhibition of phagocyte-endothelium interactions by oxidized fatty acids: A natural anti-flammatory mechanism?”,J. Lab. Clin. Med. 1996, pp. 27-38.
G.N. Levy, “Prostaglandin H synthases, nonsteriodal anti-inflammatory drugs, and colon cancer”,FASEB J. 1997, pp. 234-247.
K. Gronert, et al., “Transcellular regulation of eicosanoid biosynthesis”,Eicosanoid Protocols1999, pp. 119-144.
H.J. George et al., “Expression purification and characterization of recombinant human inductible prostaglandin G/H synthase from baculovirus-infected insect cells”,Protein Expres. Purif. 1996, pp. 19-26.
J.H. Capdevila et al., “The highly stereoselective oxidation of polyunsaturated fatty acids by cytochrome P450BM-3”,J. Biol. Chem. 1996, pp. 22663-22671.
R.T. Ruettinger et al., “Epoxidation of unsaturated fatty acids by a soluble cytochrome P-45-dependent system from bacillus megaterium”,J. Biol. Chem. 1981, pp. 5728-5734.
T.H. Lee et al., “Characterization and biologic properties of 5,12-dihydroxy derivatives of eicosapentaenoic acid, including leukotriene B5 and the double lipoxygenase product”,J. Biol. Chem. 1984, pp. 2383-2389.
C.N. Serhan et a.; “Nomenclature of lipoxins and related compounds dervived from arachidonic acid and eicosapentaenoic acid”,Prostaglandins1987, pp. 201-204.
D.J. Hill et al., “Trout thrombocytes contain 12-but not 5-lipoxygenase activity”,Biochim. Biophys. Acta1999, pp. 63-70.
B.N. Cronstein et al., “A mechanism for the anti-inflammatory effects of corticosteriods: The glucocorticoid receptor regulates leukocyte adhesion to endotheliasl cells and expression of endothelial-leukocyte adhesion molecule 1 and intercellular molecule 1”,Proc. Natl. Acad. Sci. 1992, pp. 9991-9995.
T. Yokomizo et al., “A G-protein-coupled receptor for leukotriene B4 that mediates chemotaxis”,Nature1997, pp. 620-624.
M.R. Buchanan et al., “Regulation of endothelial cell and platelet receptor-ligand binding by the 12-and 15-lipoxygenase monohydroxides, 12-, 15-HETE and 13-HODE”,Prostaglandias Leukot. Essen. Fatty Acids1998, pp. 339-346.
P.M. Ridker et al., “Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men”,N. Engl. J. Med. 1997, pp. 973-979.
Communication Relating to the Results of the Partial International Search.
Takeshi Terano, Ensho, Chemical Abstract 107:22439, pp. 63-71, 1987.
Miller et al., Lipids, Chemical Abstract 112:117062, pp. 998-1003, 1989.
Hill, EM. Proc R. Soc. London Ser. B., 247 (1318) pp. 41-46, 1992.
Eritsland et al., “Effects of Highly Concentrated Omega-3 PUF As and Acetylsalicylic Acid, Alone and Combined, on Bleeding Time and Serum Liquid Profile”,J, Olso City Hosp., vol. 39 (8-9), pp. 97-101, 1989.
Iacoviello et al., “Modulation of Fibrinolytic Response to Venous Occlusion in Humans by a Combination of Low-Dose Aspirin and n-3 PUFAs”,Arteriosclerosis Thrombosis, vol. 10, pp. 1191-1197, 1992.
Lau et al., “Effects of Fish Oil Supplementation on Non-Steroidal Anti-Inflammatory Drug (NSAID) Requirement in Patients with Mild Rheumatoid Arthritis—A Double-Blind Placebo Controlled Study”,British Journal of Rheumatology, vol. 32 (11), pp. 982-989. 1993.
Rao et al., “Comparative Pharmacology of Cyclooxygenase Inhibitors on Platelet Function”,Prostaglandins Leukot. Med., vol. 18 (1), pp. 119-131, 1985.

Affiliated with

Also associated with

Rating

Aspirin-triggered lipid mediators does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Aspirin-triggered lipid mediators, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Aspirin-triggered lipid mediators will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3576849